Advertisement

Merkel Cell Carcinoma

Published:October 27, 2022DOI:https://doi.org/10.1016/j.det.2022.07.015

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Dermatologic Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Harms K.L.
        • Healy M.A.
        • Nghiem P.
        • et al.
        Analysis of prognostic factors from 9387 Merkel cell carcinoma cases forms the basis for the new 8th edition AJCC staging system.
        Ann Surg Oncol. 2016; 23: 3564-3571
      1. National Comprehensive Care Network Clinical Practice Guidelines in Oncology (NCCN Guidelines): Merkel Cell Carcinoma, Version 1.2021. 2021.

        • Paulson K.G.
        • Park S.Y.
        • Vandeven N.A.
        • et al.
        Merkel cell carcinoma: current US incidence and projected increases based on changing demographics.
        J Am Acad Dermatol. 2018; 78: 457-463 e452
        • Kieny A.
        • Cribier B.
        • Meyer N.
        • et al.
        Epidemiology of Merkel cell carcinoma. A population-based study from 1985 to 2013, in northeastern of France.
        Int J Cancer. 2019; 144: 741-745
        • Youlden D.R.
        • Soyer H.P.
        • Youl P.H.
        • et al.
        Incidence and survival for Merkel cell carcinoma in Queensland, Australia, 1993-2010.
        JAMA Dermatol. 2014; 150: 864-872
        • Song P.I.
        • Liang H.
        • Wei W.Q.
        • et al.
        The clinical profile of Merkel cell carcinoma in mainland China.
        Int J Dermatol. 2012; 51: 1054-1059
        • Aw D.
        • Silva A.B.
        • Palmer D.B.
        Immunosenescence: emerging challenges for an ageing population.
        Immunology. 2007; 120: 435-446
        • Moll R.
        • Lowe A.
        • Laufer J.
        • et al.
        Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies.
        Am J Pathol. 1992; 140: 427-447
        • Agelli M.
        • Clegg L.X.
        • Becker J.C.
        • et al.
        The etiology and epidemiology of Merkel cell carcinoma.
        Curr Probl Cancer. 2010; 34: 14-37
        • Albores-Saavedra J.
        • Batich K.
        • Chable-Montero F.
        • et al.
        Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study.
        J Cutan Pathol. 2010; 37: 20-27
        • Paulson K.G.
        • Iyer J.G.
        • Blom A.
        • et al.
        Systemic immune suppression predicts diminished Merkel cell carcinoma-specific survival independent of stage.
        J Invest Dermatol. 2013; 133: 642-646
        • Feng H.
        • Shuda M.
        • Chang Y.
        • et al.
        Clonal integration of a polyomavirus in human Merkel cell carcinoma.
        Science. 2008; 319: 1096-1100
        • Chen T.
        • Hedman L.
        • Mattila P.S.
        • et al.
        Serological evidence of Merkel cell polyomavirus primary infections in childhood.
        J Clin Virol. 2011; 50: 125-129
        • Tolstov Y.L.
        • Pastrana D.V.
        • Feng H.
        • et al.
        Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays.
        Int J Cancer. 2009; 125: 1250-1256
        • Church CD P.N.
        How does the Merkel polyomavirus lead to a lethal cancer? Many answers, many questions, and a new mouse model.
        J Invest Dermatol. 2015; 135: 1221-1224
        • Garneski K.M.
        • Warcola A.H.
        • Feng Q.
        • et al.
        Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumors.
        J Invest Dermatol. 2009; 129: 246-248
        • Starrett G.J.
        • Marcelus C.
        • Cantalupo P.G.
        • et al.
        Merkel cell polyomavirus exhibits dominant control of the tumor genome and transcriptome in virus-associated Merkel cell carcinoma.
        mBio. 2017; 8 (e02079–16)
        • Hesbacher S.
        • Pfitzer L.
        • Wiedorfer K.
        • et al.
        RB1 is the crucial target of the Merkel cell polyomavirus large T antigen in Merkel cell carcinoma cells.
        Oncotarget. 2016; 7: 32956-32968
        • Harms P.W.
        • Vats P.
        • Verhaegen M.E.
        • et al.
        The distinctive mutational spectra of polyomavirus-negative Merkel cell carcinoma.
        Cancer Res. 2015; 75: 3720-3727
        • Goh G.
        • Walradt T.
        • Markarov V.
        • et al.
        Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy.
        Oncotarget. 2016; 7: 3403-3415
        • Wong S.Q.
        • Waldeck K.
        • Vergara I.A.
        • et al.
        UV-associated mutations underlie the etiology of mcv-negative Merkel cell carcinomas.
        Cancer Res. 2015; 75: 5228-5234
        • Tilling T.
        • Wladykowski E.
        • Failla A.V.
        • et al.
        Immunohistochemical analyses point to epidermal origin of human Merkel cells.
        Histochem Cell Biol. 2014; 141: 407-421
        • Szeder V.
        • Grim M.
        • Halata Z.
        • et al.
        Neural crest origin of mammalian Merkel cells.
        Dev Biol. 2003; 253: 258-263
        • Zur Hausen A.
        • Rennspiess D.
        • Winnepenninckx V.
        • et al.
        Early B-cell differentiation in Merkel cell carcinomas: clues to cellular ancestry.
        Cancer Res. 2013; 73: 4982-4987
        • Becker J.C.
        Merkel cell carcinoma.
        Ann Oncol. 2010; 21: vii81-vii85
        • Liu W.
        • MacDonald M.
        • You J.
        Merkel cell polyomavirus infection and Merkel cell carcinoma.
        Curr Opin Virol. 2016; 2016: 20-27
        • Nirenberg A.
        • Steinman H.
        • Dixon J.
        • et al.
        Merkel cell carcinoma update: the case for two tumours.
        J Eur Acad Dermatol Venereol. 2020; 34: 1425-1431
        • Heath M.
        • Jaimes N.
        • Lemos B.
        • et al.
        Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the “AEIOU” features.
        J Am Acad Dermatol. 2008; 58: 375-381
        • Svensson H.
        • Paoli J.
        Merkel cell carcinoma is still an unexpected diagnosis.
        J Eur Acad Dermatol Venereol. 2021; 35: e883-e884
        • Tetzlaff M.T.
        • Nagarajan P.
        Update on Merkel cell carcinoma.
        Head Neck Pathol. 2018; 12: 31-43
        • Jour G.
        • Aung P.P.
        • Rozas-Munoz E.
        • et al.
        Intraepidermal Merkel cell carcinoma: a case series of a rare entity with clinical follow up.
        J Cutan Pathol. 2017; 44: 684-691
        • Coggshall K.
        • Tello T.L.
        • North J.P.
        • et al.
        Merkel cell carcinoma: an update and review: pathogenesis, diagnosis, and staging.
        J Am Acad Dermatol. 2018; 78: 433-442
        • Chan J.K.
        • Suster S.
        • Wenig B.M.
        • et al.
        Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites.
        Am J Surg Pathol. 1997; 21: 226-234
        • Fantini F.
        • Johansson O.
        Neurochemical markers in human cutaneous Merkel cells. An immunohistochemical investigation.
        Exp Dermatol. 1995; 4: 365-371
        • Calder K.B.
        • Coplowitz S.
        • Schlauder S.
        • et al.
        A case series and immunophenotypic analysis of CK20-/CK7+ primary neuroendocrine carcinoma of the skin.
        J Cutan Pathol. 2007; 34: 918-923
        • Bobos M.
        • Hytiroglou P.
        • Kostopoulos I.
        • et al.
        Immunohistochemical distinction between Merkel cell carcinoma and small cell carcinoma of the lung.
        Am J Dermatopathol. 2006; 28: 99-104
      2. Amin MB, Gress DM, Meyer Vega LR, et al. AJCC Cancer Staging Manual. Eighth Edition. 2018.

        • Amin M.B.
        • Greene F.L.
        • Edge S.B.
        • et al.
        The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging.
        CA Cancer J Clin. 2017; 67: 93-99
        • Tarantola T.I.
        • Vallow L.A.
        • Halyard M.Y.
        • et al.
        Prognostic factors in Merkel cell carcinoma: analysis of 240 cases.
        J Am Acad Dermatol. 2013; 68: 425-432
        • Sridharan V.
        • Muralidhar V.
        • Margalit D.N.
        • et al.
        Merkel cell carcinoma: a population analysis on survival.
        J Natl Compr Canc Netw. 2016; 14: 1247-1257
        • Paulson K.G.
        • Iyer J.G.
        • Simonson W.T.
        • et al.
        CD8+ lymphocyte intratumoral infiltration as a stage-independent predictor of Merkel cell carcinoma survival: a population-based study.
        Am J Clin Pathol. 2014; 142: 452-458
        • Paulson K.G.
        • Iyer J.G.
        • Tegeder A.R.
        • et al.
        Transcriptome-wide studies of Merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival.
        J Clin Oncol. 2011; 29: 1539-1546
        • Singh N.
        • Alexander N.A.
        • Lachance K.
        • et al.
        Clinical benefit of baseline imaging in Merkel cell carcinoma: analysis of 584 patients.
        J Am Acad Dermatol. 2021; 84: 330-339
        • Park S.Y.
        • Doolittle-Amieva C.
        • Moshiri Y.
        • et al.
        How we treat Merkel cell carcinoma: within and beyond current guidelines.
        Future Oncol. 2021; 17: 1363-1377
        • Lewis D.J.
        • Fathy R.A.
        • Nugent S.
        • et al.
        Sentinel lymph node biopsy in Merkel cell carcinoma: Rates and predictors of compliance with the National Comprehensive Cancer Network guidelines.
        J Am Acad Dermatol. 2022; https://doi.org/10.1016/j.jaad.2022.05.054
        • Allen P.J.
        • Bowne W.B.
        • Jaques D.P.
        • et al.
        Merkel cell carcinoma: prognosis and treatment of patients from a single institution.
        J Clin Oncol. 2005; 23: 2300-2309
        • Schwartz J.L.
        • Griffith K.A.
        • Lowe L.
        • et al.
        Features predicting sentinel lymph node positivity in Merkel cell carcinoma.
        J Clin Oncol. 2011; 29: 1036-1041
        • Iyer J.G.
        • Storer B.E.
        • Paulson K.G.
        • et al.
        Relationships among primary tumor size, number of involved nodes, and survival for 8044 cases of Merkel cell carcinoma.
        J Am Acad Dermatol. 2014; 70: 637-643
        • Fields R.C.
        • Busam K.J.
        • Chou J.F.
        • et al.
        Recurrence and survival in patients undergoing sentinel lymph node biopsy for Merkel cell carcinoma: analysis of 153 patients from a single institution.
        Ann Surg Oncol. 2011; 18: 2529-2537
        • Conic R.R.Z.
        • Ko J.
        • Saridakis S.
        • et al.
        Sentinel lymph node biopsy in Merkel cell carcinoma: predictors of sentinel lymph node positivity and association with overall survival.
        J Am Acad Dermatol. 2019; 81: 364-372
        • Lemos B.D.
        • Storer B.E.
        • Iyer J.G.
        • et al.
        Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system.
        J Am Acad Dermatol. 2010; 63: 751-761
        • Sims J.R.
        • Grotz T.E.
        • Pockaj B.A.
        • et al.
        Sentinel lymph node biopsy in Merkel cell carcinoma: the Mayo Clinic experience of 150 patients.
        Surg Oncol. 2018; 27: 11-17
        • Gupta S.G.
        • Wang L.C.
        • Penas P.F.
        • et al.
        Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: the Dana-Farber experience and meta-analysis of the literature.
        Arch Dermatol. 2006; 142: 685-690
        • Cornejo C.
        • Miller C.J.
        Merkel cell carcinoma: updates on staging and management.
        Dermatol Clin. 2019; 37: 269-277
        • Perez M.C.
        • de Pinho F.R.
        • Holstein A.
        • et al.
        Resection margins in Merkel cell carcinoma: is a 1-cm margin wide enough?.
        Ann Surg Oncol. 2018; 25: 3334-3340
        • Gillenwater A.M.
        • Hessel A.C.
        • Morrison W.H.
        • et al.
        Merkel cell carcinoma of the head and neck: effect of surgical excision and radiation on recurrence and survival.
        Arch Otolaryngol Head Neck Surg. 2001; 127: 149-154
        • Gollard R.
        • Weber R.
        • Kosty M.P.
        • et al.
        Merkel cell carcinoma: review of 22 cases with surgical, pathologic, and therapeutic considerations.
        Cancer. 2000; 88: 1842-1851
        • Yiengpruksawan A.
        • Coit D.G.
        • Thaler H.T.
        • et al.
        Merkel cell carcinoma. Prognosis and management.
        Arch Surg. 1991; 126: 1514-1519
        • Singh B.
        • Qureshi M.M.
        • Truong M.T.
        • et al.
        Demographics and outcomes of stage I and II Merkel cell carcinoma treated with Mohs micrographic surgery compared with wide local excision in the National Cancer Database.
        J Am Acad Dermatol. 2018; 79: 126-134 e123
        • O'Connor W.J.
        • Roenigk R.K.
        • Brodland D.G.
        Merkel cell carcinoma. Comparison of Mohs micrographic surgery and wide excision in eighty-six patients.
        Dermatol Surg. 1997; 23: 929-933
        • Harrington C.
        • Kwan W.
        Radiotherapy and conservative surgery in the locoregional management of Merkel cell carcinoma: the British Columbia Cancer Agency experience.
        Ann Surg Oncol. 2016; 23: 573-578
        • Tarabadkar E.S.
        • Fu T.
        • Lachance K.
        • et al.
        Narrow excision margins are appropriate for Merkel cell carcinoma when combined with adjuvant radiation: Analysis of 188 cases of localized disease and proposed management algorithm.
        J Am Acad Dermatol. 2021; 84: 340-347
        • Terushkin V.
        • Brodland D.G.
        • Sharon D.J.
        • et al.
        Mohs surgery for early-stage Merkel cell carcinoma (MCC) achieves local control better than wide local excision +/- radiation therapy with no increase in MCC-specific death.
        Int J Dermatol. 2021; 60: 1010-1012
        • Boyer J.D.
        • Zitelli J.A.
        • Brodland D.G.
        • et al.
        Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation.
        J Am Acad Dermatol. 2002; 47: 885-892
        • Shaikh W.R.
        • Sobanko J.F.
        • Etzkorn J.R.
        • et al.
        Utilization patterns and survival outcomes after wide local excision or Mohs micrographic surgery for Merkel cell carcinoma in the United States, 2004-2009.
        J Am Acad Dermatol. 2018; 78: 175-177 e173
        • Carrasquillo O.Y.
        • Cancel-Artau K.J.
        • Ramos-Rodriguez A.J.
        • et al.
        Mohs micrographic surgery versus wide local excision in the treatment of merkel cell carcinoma: a systematic review.
        Dermatol Surg. 2021; 48: 176-180
        • Su C.
        • Bai H.X.
        • Christensen S.
        Relative survival analysis in patients with stage I-II Merkel cell carcinoma treated with Mohs micrographic surgery or wide local excision.
        J Am Acad Dermatol. 2018; (S0190-9622(18)30816-8. Epub ahead of print)
        • Harrington C.
        • Kwan W.
        Outcomes of Merkel cell carcinoma treated with radiotherapy without radical surgical excision.
        Ann Surg Oncol. 2014; 21: 3401-3405
        • Veness M.
        • Howle J.
        Radiotherapy alone in patients with Merkel cell carcinoma: the Westmead Hospital experience of 41 patients.
        Australas J Dermatol. 2015; 56: 19-24
        • Bhatia S.
        • Storer B.E.
        • Iyer J.G.
        • et al.
        Adjuvant radiation therapy and chemotherapy in Merkel cell carcinoma: survival analyses of 6908 cases from the national cancer data base.
        J Natl Cancer Inst. 2016; 108: djw042
        • Takagishi S.R.
        • Marx T.E.
        • Lewis C.
        • et al.
        Postoperative radiation therapy is associated with a reduced risk of local recurrence among low risk Merkel cell carcinomas of the head and neck.
        Adv Radiat Oncol. 2016; 1: 244-251
        • Mojica P.
        • Smith D.
        • Ellenhorn J.
        Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin.
        J Clin Oncol. 2007; 25: 1043-1047
        • Cook M.M.
        • Schaub S.K.
        • Goff P.H.
        • et al.
        Postoperative, single-fraction radiation therapy in Merkel cell carcinoma of the head and neck.
        Adv Radiat Oncol. 2020; 5: 1248-1254
        • Iyer J.G.
        • Parvathaneni U.
        • Gooley T.
        • et al.
        Single-fraction radiation therapy in patients with metastatic Merkel cell carcinoma.
        Cancer Med. 2015; 4: 1161-1170
        • Grotz T.E.
        • Joseph R.W.
        • Pockaj B.A.
        • et al.
        Negative sentinel lymph node biopsy in Merkel cell carcinoma is associated with a low risk of same-nodal-basin recurrences.
        Ann Surg Oncol. 2015; 22: 4060-4066
        • Fang L.C.
        • Lemos B.
        • Douglas J.
        • et al.
        Radiation monotherapy as regional treatment for lymph node-positive Merkel cell carcinoma.
        Cancer. 2010; 116: 1783-1790
        • Topalian S.L.
        • Bhatia S.
        • Amin A.
        • et al.
        Neoadjuvant nivolumab for patients with resectable Merkel cell carcinoma in the checkmate 358 trial.
        J Clin Oncol. 2020; 38: 2476-2487
        • Prieto I.
        • Perez de la Fuente T.
        • Medina S.
        • et al.
        Merkel cell carcinoma: an algorithm for multidisciplinary management and decision-making.
        Crit Rev Oncol Hematol. 2016; 98: 170-179
        • Iyer J.G.
        • Afanasiev O.K.
        • McClurkan C.
        • et al.
        Merkel cell polyomavirus-specific CD8(+) and CD4(+) T-cell responses identified in Merkel cell carcinomas and blood.
        Clin Cancer Res. 2011; 17: 6671-6680
        • Lyngaa R.
        • Pedersen N.W.
        • Schrama D.
        • et al.
        T-cell responses to oncogenic Merkel cell polyomavirus proteins distinguish patients with Merkel cell carcinoma from healthy donors.
        Clin Cancer Res. 2014; 20: 1768-1778
        • Afanasiev O.K.
        • Yelistratova L.
        • Miller N.
        • et al.
        Merkel polyomavirus-specific T cells fluctuate with Merkel cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers.
        Clin Cancer Res. 2013; 19: 5351-5360
        • D'Angelo S.P.
        • Russell J.
        • Lebbe C.
        • et al.
        Efficacy and safety of first-line avelumab treatment in patients with stage IV metastatic Merkel cell carcinoma: a preplanned interim analysis of a clinical trial.
        JAMA Oncol. 2018; 4: e180077
        • Nghiem P.T.
        • Bhatia S.
        • Lipson E.J.
        • et al.
        PD-1 blockade with pembrolizumab in advanced Merkel-cell carcinoma.
        N Engl J Med. 2016; 374: 2542-2552
        • Ngheim P.
        • Bhatia S.
        • Lipson E.J.
        • et al.
        Durable tumor regression and overall survival in patients with advanced Merkel cell carcinoma receiving pembrolizumab as first-line therapy.
        J Clin Oncol. 2019; 37: 693-702
        • Kaufman H.L.
        • Russell J.
        • Hamid O.
        • et al.
        Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial.
        Lancet Oncol. 2016; 17: 1374-1385
        • Nghiem P.
        • Bhatia S.
        • Lipson E.J.
        • et al.
        Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma.
        J Immunother Cancer. 2021; 9: e002478
        • D'Angelo S.P.
        • Bhatia S.
        • Brohl A.S.
        • et al.
        Avelumab in patients with previously treated metastatic Merkel cell carcinoma (JAVELIN Merkel 200): updated overall survival data after >5 years of follow-up.
        ESMO Open. 2021; 6: 100290
        • Glutsch V.
        • Kneitz H.
        • Gesierich A.
        • et al.
        Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma.
        Cancer Immunol Immunother. 2021; 70: 2087-2093
        • Khaddour K.
        • Rosman I.S.
        • Dehdashti F.
        • et al.
        Durable remission after rechallenge with ipilimumab and nivolumab in metastatic Merkel cell carcinoma refractory to avelumab: any role for sequential immunotherapy?.
        J Dermatol. 2021; 48: e80-e81
        • Iyer J.G.
        • Blom A.
        • Doumani R.
        • et al.
        Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma.
        Cancer Med. 2016; 5: 2294-2301
        • Voog E.
        • Biron P.
        • Martin J.P.
        • et al.
        Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma.
        Cancer. 1999; 85: 2589-2595
        • Cimbak N.
        • Barker Jr., C.A.
        Short-course radiation therapy for Merkel cell carcinoma: relative effectiveness in a ‘‘radiosensitive’’ tumor.
        Int J Radiat Oncol. 2016; 96: S160
        • Lee Y.
        • Auh S.L.
        • Wang Y.
        • et al.
        Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment.
        Blood. 2009; 114: 589-595
        • Bhatia S.
        • Miller N.J.
        • Lu H.
        • et al.
        Intratumoral G100, a TLR4 agonist, induces antitumor immune responses and tumor regression in patients with Merkel cell carcinoma.
        Clin Cancer Res. 2019; 25: 1185-1195
        • Bhatia S.
        • Longino N.V.
        • Miller N.J.
        • et al.
        Intratumoral delivery of plasmid IL12 via electroporation leads to regression of injected and noninjected tumors in Merkel cell carcinoma.
        Clin Cancer Res. 2020; 26: 598-607
        • Westbrook B.C.
        • Norwood T.G.
        • Terry N.L.J.
        • et al.
        Talimogene laherparepvec induces durable response of regionally advanced Merkel cell carcinoma in 4 consecutive patients.
        JAAD Case Rep. 2019; 5: 782-786
        • Joshi T.P.
        • Farr M.A.
        • Hsiou D.A.
        • et al.
        Therapeutic targets for vaccination in polyomavirus-driven Merkel cell carcinoma.
        Dermatol Ther. 2022; 35: e15580
        • Goff P.H.
        • Bhakuni R.
        • Pulliam T.
        • et al.
        Intersection of two checkpoints: could inhibiting the DNA damage response checkpoint rescue immune checkpoint-refractory cancer?.
        Cancers (Basel). 2021; 13: 3415
        • Park D.E.
        • Cheng J.
        • Berrios C.
        • et al.
        Dual inhibition of MDM2 and MDM4 in virus-positive Merkel cell carcinoma enhances the p53 response.
        Proc Natl Acad Sci U S A. 2019; 116: 1027-1032
        • Song L.
        • Bretz A.C.
        • Gravemeyer J.
        • et al.
        The HDAC inhibitor domatinostat promotes cell-cycle arrest, induces apoptosis, and increases immunogenicity of Merkel cell carcinoma cells.
        J Invest Dermatol. 2021; 141: 903-912 e904
        • Bichakjian C.K.
        • Lowe L.
        • Lao C.D.
        • et al.
        Merkel cell carcinoma: critical review with guidelines for multidisciplinary management.
        Cancer. 2007; 110: 1-12
        • Samimi M.
        • Molet L.
        • Fleury M.
        • et al.
        Prognostic value of antibodies to Merkel cell polyomavirus T antigens and VP1 protein in patients with Merkel cell carcinoma.
        Br J Dermatol. 2016; 174: 813-822
        • Paulson K.G.
        • Lewis C.W.
        • Redman M.W.
        • et al.
        Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: a prospective validation study.
        Cancer. 2017; 123: 1464-1474
        • Riethdorf S.
        • Hildebrandt L.
        • Heinzerling L.
        • et al.
        Detection and characterization of circulating tumor cells in patients with Merkel cell carcinoma.
        Clin Chem. 2019; 65: 462-472